Năm 2013 sẽ có vắcxin cúm H5N1 ‘made in’ Việt Nam
Nghiên cứu vắcxin H5N1 trên người đang ở giai đoạn 3, thử nghiệm trên quần thể lớn về tính an toàn, sinh miễn dịch và hiệu quả bảo vệ. Đây là cơ sở trình Bộ y tế để đưa văcxin vào sản xuất và sử dụng ở người.
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